title: Cancer: Where were we, where are we, where are we going.
abstract: Cancer diagnosis, medicine, prevention and care is changing - all for the better. As opposed to the "old days" of luck, trial and error and toxicity, we are now entering a new dawn due to advances in genomics and our understanding of biology. Personalised medicine or PM (aspects of which may also be referred to as precision medicine) is a medical model that proposes the customisation of healthcare - with medical decisions, practices, and/or products being tailored to the individual patient. This talk examines how this has evolved in the field of oncology, to maximise benefits to our patients and minimise toxicity, being able to predict in advance who our therapies will work for.
authors.affiliation: Faculty of Medicine, Department of Surgery & Cancer, Imperial College, London, UK.
authors.forename: Justin
authors.initials: J
authors.lastname: Stebbing
keywords: Precision; druggable; evolution; genomics; oncogene; predictability; proteomics